# Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis

Study · id `cardio:ct-nct04982367` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04982367](<https://clinicaltrials.gov/study/NCT04982367>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04982367

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 166 participants.

## Technical summary

Registry record NCT04982367. Randomized; no masking; primary purpose treatment. Start 2021-12-08 (actual); primary completion 2024-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 166 participants (planned count; ClinicalTrials.gov record NCT04982367, source copy `cardio:ctgov-nct04982367-2023-10-18`, retrieved 2026-10-31)
- Started: 2021-12-08 (actual) (ClinicalTrials.gov record NCT04982367, source copy `cardio:ctgov-nct04982367-2023-10-18`, retrieved 2026-10-31)
- Primary completion: 2024-07 (anticipated) (ClinicalTrials.gov record NCT04982367, source copy `cardio:ctgov-nct04982367-2023-10-18`, retrieved 2026-10-31)
- Completion: 2024-07 (anticipated) (ClinicalTrials.gov record NCT04982367, source copy `cardio:ctgov-nct04982367-2023-10-18`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT04982367, source copy `cardio:ctgov-nct04982367-2023-10-18`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04982367-2023-10-18`, retrieved 2026-10-31)

## The registry's words

- Brief title: Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis
- Condition: Peripheral Artery Disease
- Intervention (Device): Sirolimus-eluting balloon catheter
- Intervention (Device): Paclitaxel-eluting balloon catheter
- Lead sponsor: Acotec Scientific Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Acotec Scientific Co., Ltd (`cardio:org-acotec-scientific-co-ltd`)

## Provenance

Content hash: b2e8a152d7bd5a011e0f267d3eb6a38b8fc01c81d232917156197637299e7338
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
